Cargando…
Evaluating Pharmacokinetic and Pharmacodynamic Interactions with Computational Models in Supporting Cumulative Risk Assessment
Simultaneous or sequential exposure to multiple chemicals may cause interactions in the pharmacokinetics (PK) and/or pharmacodynamics (PD) of the individual chemicals. Such interactions can cause modification of the internal or target dose/response of one chemical in the mixture by other chemical(s)...
Autores principales: | Tan, Yu-Mei, Clewell, Harvey, Campbell, Jerry, Andersen, Melvin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108131/ https://www.ncbi.nlm.nih.gov/pubmed/21655141 http://dx.doi.org/10.3390/ijerph8051613 |
Ejemplares similares
-
A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment.
por: Clewell, Harvey J, et al.
Publicado: (2002) -
Incorporation of rapid association/dissociation processes in tissues into the monkey and human physiologically based pharmacokinetic models for manganese
por: Campbell, Jerry L, et al.
Publicado: (2022) -
A Kinetic Analysis of DNA-Deoxy Guanine Adducts in the Nasal Epithelium Produced by Inhaled Formaldehyde in Rats—Assessing Contributions to Adduct Production From Both Endogenous and Exogenous Sources of Formaldehyde
por: Campbell Jr, Jerry L, et al.
Publicado: (2020) -
Update on a Pharmacokinetic-Centric Alternative Tier II Program for MMT—Part II: Physiologically Based Pharmacokinetic Modeling and Manganese Risk Assessment
por: Taylor, Michael D., et al.
Publicado: (2012) -
PBPK-Based Probabilistic Risk Assessment for Total Chlorotriazines in Drinking Water
por: Breckenridge, Charles B., et al.
Publicado: (2016)